HDAC6 and prostate carcinoma: In prostate cancer cells, deacetylated Hsp90 binds to and stabilizes the androgen receptor (AR), while the HDAC6 suppressor sulforaphane led to increased levels of acetylated Hsp90 accompanied by enhanced AR degradation [36].